Europe Lymphedema Treatment Market - Industry Trends and Forecast to 2032
Europe Lymphedema Treatment Market is expected to reach USD 505,228.14 thousand by 2030 from USD 271,206.43 thousand in 2022 growing at the CAGR of 8.3% in the forecast period of 2023 to 2030.
Market SegmentationEurope Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others), Treatment (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity, and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable, and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics and Others), Distribution Channel (Direct tender, Pharmacy stores, and Others), Country (Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Lymphedema Treatment Market Dynamics
Driver
• Availability of multiple therapies
Restrain
• High costs of treatment
Opportunity
• Increasing drug approvals
Market PlayersSome of the key market players operating in the Europe lymphedema treatment market are listed below:• medi GmbH & Co. KG
• PAUL HARTMANN AG
• 3M
• Convatec Inc.
• JUZO
• SIGVARIS GROUP
• Sanyleg Srl a socio unico
• AIROS Medical, Inc.
• Tactile Medical
• BIOCOMPRESSION SYSTEMS
• Lohmann & Rauscher GmbH & Co. KG
• Mego Afek ltd.
• Cardinal Health
• Essity (BSN medical GmbH)
• Smith+Nephew
• Huntleigh Healthcare Limited
• Avet Pharmaceuticals Inc
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.